StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) stock

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/3017% below fair value
$26.41−0.22 (-0.83%)

Close on Nov 20, 2026Market cap $1.36BP/E –Yield 0.00%

Immunocore shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Immunocore's shares outstanding was 51M at Jun 30, 2026. For fiscal 2025 it was 50M, up 0.7% from the year before. The highest annual figure on record is 50M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202550M+0.7%
FY2024Dec 31, 202450M+2.3%
FY2023Dec 31, 202349M+6.9%
FY2022Dec 31, 202246M+7.6%
FY2021Dec 31, 202142M+60.2%
FY2020Dec 31, 202027M+19.0%
FY2019Dec 31, 201922M+3.4%
FY2018Dec 31, 201822M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202651M+1.4%
Q1 FY2026Mar 31, 202653M+1.9%
Q4 FY2025Dec 31, 202551M+1.1%
Q3 FY2025Sep 30, 202550M-4.6%
Q2 FY2025Jun 30, 202550M+0.6%
Q1 FY2025Mar 31, 202552M+4.2%
Q4 FY2024Dec 31, 202450M+1.0%
Q3 FY2024Sep 30, 202453M-2.5%
Q2 FY2024Jun 30, 202450M+2.7%
Q1 FY2024Mar 31, 202450M+3.5%
Q4 FY2023Dec 31, 202350M+3.2%
Q3 FY2023Sep 30, 202354M+5.3%
Q2 FY2023Jun 30, 202349M+10.8%
Q1 FY2023Mar 31, 202348M+9.9%
Q4 FY2022Dec 31, 202248M+9.7%
Q3 FY2022Sep 30, 202251M–
Q2 FY2022Jun 30, 202244M–
Q4 FY2021Dec 31, 202144M–
Q3 FY2021Sep 30, 202144M–

More Immunocore figures

See a number that looks wrong?